Silver nanoparticles-modified films versus biomedical device-associated infections

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 2, Issue 6, 2010, Pages 670-684

  Cao, Huiliang ^a   Liu, Xuanyong ^a  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBACTERIAL PROPERTIES; BACTERIAL INFECTIONS; BIOMEDICAL DEVICES; FABRICATION PROCESS; MAMMALIAN CELLS; MATERIAL SCIENTISTS; MODIFIED FILM; POTENTIAL APPLICATIONS; REDUCTION AGENTS; SILVER NANOPARTICLES; SILVER PARTICLES; SURFACE MODIFICATION PROCESS;

BACTERIOLOGY; MAMMALS; NANOPARTICLES; SPACE SHUTTLES;

SILVER;

NANOFILM; PENICILLIN G; SILVER; SILVER NANOPARTICLE; SILVER NITRATE; SULFADIAZINE SILVER; TITANIUM; TITANIUM DIOXIDE; ANTIINFECTIVE AGENT; METAL NANOPARTICLE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BACTERIUM; BURN; CYTOTOXICITY; DEVICE; DEVICE INFECTION; HOSPITAL INFECTION; HUMAN; MAMMAL CELL; MEDICAL INSTRUMENTATION; MULTIDRUG RESISTANCE; NANOFABRICATION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REVIEW; SAFETY; VAPOR; WOUND HEALING; CHEMISTRY; INFECTION;

ANTI-BACTERIAL AGENTS; HUMANS; METAL NANOPARTICLES; PROSTHESIS-RELATED INFECTIONS; SILVER;

EID: 79952196710     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.113     Document Type: Review

References (143)

1. Agarwal A, Weis TL, Schurr MJ, Faith NG, Czuprynski CJ. Surfaces modified with nanometer-thick silver-impregnated polymeric films that kill bacteria but support growth of mammalian cells. Biomaterials 2010, 31:680-690.
2. Nazhat SN, Young AM, Pratten J. Sterility and infection. In: Narayan R, eds. Biomedical Materials. New York: Springer; 2009.
3. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999, 284:1318-1322.
4. Long PH. Medical devices in orthopedic applications. Toxicol Pathol 2008, 36:85-91.
5. Rodríguez D, Pigrau C, Euba G, Cobo J, García-Lechuz J, Palomino J, Riera M, Del Toro MD, Granados A, Ariza X. Acute hematogenous prosthetic joint infection: prospective evaluation of medical and surgical management. Clin Microbiol Infect 2009, doi:10.1111/j.1469-0691.2010.03157.x.
6. Johannsson B, Callaghan JJ. Prosthetic hip infection due to Cryptococcus neoformans: case report. Diagn Microbiol Infect Dis 2009, 64:76-79.
7. Ochoa RAT, Mow CS. Deep infection of a total knee implant as a complication of disseminated pneumococcal sepsis. a case report and review of literature. The Knee 2008, 15:144-147.
8. Brady RA, Calhoun JH, Leid JG, Shirtliff ME. Infections of orthopaedic implants and devices. In: Shirtliff M, Leid JG, eds. The Role of Biofilms in Device-related Infections. Berlin Heidelberg: Springer-Verlag; 2009.
9. Trampuz A, Zimmerli W. Diagnosis and treatment of infections associated with fracture-fixation devices. Injury 2006, 37:S59-S66.
10. Larwood KA. Reducing central venous catheter infections. Aust Crit Care 2000, 13:107-112.
11. Randelli P, Castagna A, Cabitza F, Cabitza P, Arrigoni P, Denti M. Infectious and thromboembolic complications of arthroscopic shoulder surgery. J Shoulder Elbow Surg 2010, 19:97-101.
12. Linberg CJ, Sperling JW, Schleck CD, Cofield RH. Shoulder arthroplasty in morbidly obese patients. J Shoulder Elbow Surg 2009, 18:903-906.
13. Carlile GS, Elvy J, Toms AD. Salmonella infection of a total knee replacement. The Knee 2009, doi:10.1016/j.knee.2009.10.003 (In Press).
14. Iyengar KP, Gudena R, Chitgopkar SD, Ralte P, Hughes P, Nadkarni JB, Loh WY. Primary septic arthritis of the acromio-clavicular joint: case report and review of literature. Arch Orthop Trauma Surg 2009, 129:83-86.
15. Jeon DW, Chang BS, Jeung UO, Lee SJ, Lee CK, Kim MS, Nam WD. A case of postoperative tuberculous spondylitis with a bizarre course. Clin Orthop Surg 2009, 1:58-62.
16. Trampuz A, Gilomen A, Fluckiger U, Frei R, Zimmerli W, Widmer A. Treatment outcome of infections associated with internal fixation devices: results from a 5-year retrospective study (1999-2003). Int J Infect Dis 2006, 10:S79.
17. Talaat M, Hafez S, Saied T, Elfeky R, El-Shoubary W. Surveillance of catheter associated urinary tract infection in 4 intensive care units at Alexandria university hospitals in Egypt. Am J Infect Control 2010, 38:222-228.
18. Leonhardt A, Renvert S, Dahlen G. Microbial findings at failing implants. Clin Oral Implants Res 1999, 10:339-345.
19. Pye AD, Lockhart DEA, Dawson MP, Murray CA, Smith AJ. A review of dental implants and infection. J Hosp Infect 2009, 72:104-110.
20. Mahomed NN, Barrett JA, Katz JN, Phillips CB, Losina E, Lew RA, Guadagnoli E, Harris WH, Poss R, Baron JA. Rates and outcomes of primary and revision total hip replacement in the United States Medicare population. J Bone Joint Surg Am 2003, 85:27-32.
21. Ridgeway S, Wilson J, Charlet A, Kafatos G, Pearson A, Coello R. Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br 2005, 87:844-850.
22. Kelm J, Schmitt E, Anagnostakos K. Vacuum-assisted closure in the treatment of early hip joint infections. Int J Med Sci 2009, 6:241-246.
23. Segawa H, Tsukayama DT, Kyle RF, Becker DA, Gustilo RB. Infection after total knee arthroplasty. J Bone Joint Surg Am 1999, 81:1434-1445.
24. Mahomed NN, Barrett J, Katz JN, Baron JA, Wright J, Losina E. Epidemiology of total knee replacement in the United States Medicare population. J Bone Joint Surg Am 2005, 87:1222-1228.
25. Meehan J, Jamal AA, Nguyen H. Prophylactic antibiotics in hip and knee arthroplasty. J Bone Joint Surg Am 2009, 91:2480-2490.
26. Lantry JM, Roberts CS, Giannoudis PV. Operative treatment of scapular fractures: a systematic review. Injury 2008, 39:271-283.
27. Cheung EV, Sperling JW, Cofield RH. Infection associated with hematoma formation after shoulder arthroplasty. Clin Orthop Relat Res 2008, 466:1363-1367.
28. Olsen MA, Nepple JJ, Riew KD, Lenke LG, Bridwell KH, Mayfield J, Fraser VJ. Risk factors for surgical site infection following orthopaedic spinal operations. J Bone Joint Surg Am 2008, 90:62-69.
29. Olsen MA, Mayfield J, Lauryssen C, Polish LB, Jones M, Vest J, Fraser VJ. Risk factors for surgical site infection in spinal surgery. J Neurosurg (Spine 2) 2003, 98:149-155.
30. Moriarty TF, Schlegel U, Perren S, Richards RG. Infection in fracture fixation: can we influence infection rates through implant design. J Mater Sci Mater Med 2010, 21:1031-1035.
31. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med 2004, 350:1422-1429.
32. Salvi GE, Furst MM, Lang NP, Persson GR. One-year bacterial colonization patterns of Staphylococcus aureus and other bacteria at implants and adjacent teeth. Clin Oral Implants Res 2008, 19:242-248.
33. De Boever AL, De Boever JA. Early colonization of non-submerged dental implants in patients with a history of advanced aggressive periodontitis. Clin Oral Implants Res 2006, 17:8-17.
34. Sahu S, Sachan S. Emergency central venous catheterization revisited. J Emerg Trauma Shock 2009, 2:218-219.
35. Lorente L, Henry C, Martín MM, Jiménez A, Mora ML. Central venous catheter-related infection in a prospective and observational study of 2, 595 catheters. Crit Care 2005, 9:R631-R635.
36. Saint S, Meddings JA, Calfee D, Kowalski CP, Krein SL. Catheter-associated urinary tract infection and the medicare rule changes. Ann Intern Med 2009, 150:877-884.
37. Elpern EH, Killeen K, Ketchem A, Wiley A, Patel G, Lateef O. Reducing use of indwelling urinary catheters and associated urinary tract infections. Am J Crit Care 2009, 18:535-541.
38. Zimmerli W. Prosthetic-joint-associated infections. Best Pract Res Clin Rheumatol 2006, 20:1045-1063.
39. Lenz AM, Fairweather M, Cheadle WG. Resistance profiles in surgical-site infection. Future Microbiol 2008, 3:453-462.
40. Dempsey KE, Riggio MP, Lennon A, Hannah VE, Ramage G, Allan D, Bagg J. Identification of bacteria on the surface of clinically infected and non-infected prosthetic hip joints removed during revision arthroplasties by 16S rRNA gene sequencing and by microbiological culture. Arthritis Res Ther 2007, 9:R46.
41. Gallo J, Raska M, Dendis M, Florschutz AV, Kolar M. Molecular diagnosis of prosthetic joint infection: a review of evidence. Biomed Pap 2004, 148:123-129.
42. Trampuz A, Piper KE, Hanssen AD, Osmon DR, Cockerill FR, Steckelberg JM, Patel R. Sonication of explanted prosthetic components in bags for diagnosis of prosthetic joint infection is associated with risk of contamination. J Clin Microbiol 2006, 44:628-631.
43. Johannsson B, Taylor J, Clark CR, Shamsuddin H, Beekmann SE, Polgreen P. Treatment approaches to prosthetic joint infections: results of an Emerging Infections Network survey. Diagn Microbiol Infect Dis 2010, 66:16-23.
44. Randelli P, Evola FR, Cabitza P, Poll L, Denti M, Vaienti L. Prophylactic use of antibiotic-loaded bone cement in primary total knee replacement. Knee Surg Sports Traumatol Arthrosc 2010, 18:181-186.
45. Namba RS, Chen Y, Paxton EW, Slipchenko T, Fithian DC. Outcomes of routine use of antibiotic-loaded cement in primary total knee arthroplasty. J Arthroplasty 2009, 24:44-47.
46. National Nosocomial Infections Surveillance (NNIS). System report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004, 32:470-485.
47. Dohmen PM. Antibiotic resistance in common pathogens reinforces the need to minimise surgical site infections. J Hosp Infect 2008, 70:15-20.
48. Davin-Regli A, Bolla JM, James CJ, Lavigne JP, Chevalier J, Garnotel E, Molitor A, Pagès JM. Membrane permeability and regulation of drug "influx and efflux" in enterobacterial pathogens. Curr Drug Targets 2008, 9:750-759.
49. Demain AL, Sanchez S. Microbial drug discovery: 80 years of progress. J Antibiot 2009, 62:5-16.
50. Hawkey PM, Jones AM. The changing epidemiology of resistance. J Antimicrob Chemother 2009, 64:i3-i10.
51. Gould IM. Antibiotic resistance: the perfect storm. Int J Antimicrob Agents 2009, 34:S2-S5.
52. Darouiche RO. Antimicrobial approaches for preventing infections associated with surgical implants. Clin Infect Dis 2003, 36:1284-1289.
53. Alexander JW. History of the medical uses of silver. Surg Infect 2009, 10:289-292.
54. Klasen HJ. Historical review of the use of silver in the treatment of burns. I. Early uses. Burns 2000, 26:117-130.
55. Klasen HJ. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns 2000, 26:131-138.
56. Chopra I. The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern? J Antimicrob Chemother 2007, 59:587-590.
57. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 2009, 27:76-83.
58. Gemmell CG, Edwards DI, Frainse AP. Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother 2006, 57:589-608.
59. Monteiro DR, Gorup LF, Takamiya AS, Ruvollo-Filho AC, de Camargo ER, Barbosa DB. The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver. Int J Antimicrob Agents 2009, 34:103-110.
60. Kazachenko AS, Legler TAV, Peryanova TOV, Vstavskaya YA. Synthesis and antimicrobial activity of silver complexes with histidine and tryptophan. Pharm Chem J 2000, 34:257-258.
61. Kumar R, Münstedt H. Silver ion release from antimicrobial polyamide/silver composites. Biomaterials 2005, 26:2081-2088.
62. Li B, Liu X, Cao C, Meng F, Dong Y, Cui, T, Ding C. Preparation and antibacterial effect of plasma sprayed wollastonite coatings loading silver. Appl Surf Sci 2008, 255:452-454.
63. Stobie N, Duffy B, McCormack DE, Colreavy J, Hidalgo M, McHale P, Hinder SJ. Prevention of Staphylococcus epidermidis biofilm formation using a low-temperature processed silver-doped phenyltriethoxy silane sol-gel coating. Biomaterials 2008, 29: 963-969.
64. Li B, Liu X, Meng F, Chang J, Ding C. Preparation and antibacterial properties of plasma sprayed nano-titania/silver coatings. Mater Chem Phys 2009, 118:99-104.
65. Rupp ME, Fitzgerald T, Marion N, Helget V, Puumala S, Anderson JR, Fey PD. Effect of silver-coated urinary catheters: efficacy, cost-effectiveness, and antimicrobial resistance. Am J Infect Control 2004, 32:445-450.
66. Taylor PL, Ussher AL, Burrell RE. Impact of heat on nanocrystalline silver dressings. Part I: Chemical and biological properties. Biomaterials 2005, 26:7221-7229.
67. Ip M, Lui SL, Poom VKM, Lung I, Burd A. Antimicrobial activities of silver dressings: an in vitro comparison. J Med Microbiol 2006, 55:59-63.
68. Yacaman MJ, Ascencio JA, Liu HB, Gardea-Torresdey J. Structure shape and stability of nanometric sized particles. J Vac Sci Technol B 2001, 19:1091-1103.
69. Fabrega J, Renshaw JC, Lead JR. Interactions of silver nanoparticles with pseudomonas putida biofilms. Environ Sci Technol 2009, 43:9004-9009.
70. Park E, Yi J, Kim Y, Choi K, Park K. Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism. Toxicol In Vitro 2010, 24:872-878.
71. Edwards-Jones V. The benefits of silver in hygiene, personal care and healthcare. Lett Appl Microbiol 2009, 49:147-152.
72. Matsumura Y, Yoshikata K, Kunisaki S, Tsuchido T. Mode of bactericidal action of silver zeolite and its comparison with that of silver nitrate. Appl Environ Microbiol 2003, 69:4278-4281.
73. Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 2000, 52:662-668.
74. Jung WK, Koo HC, Kim KW, Shin S, Kim SH, Park YH. Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl Environ Microbiol 2008, 74:2171-2178.
75. Dibrov P, Dzioba J, Gosink KK, Hase CC. Chemiosmotic mechanism of antimicrobial activity of Ag+ in Vibrio cholerae. Antimicrob Agents Chemother 2002, 46:2668-2670.
76. Moore KJ, Angevine CM, Vincent OD, Schwem BE, Fillingame RH. The cytoplasmic loops of subunit a of Escherichia coli ATP synthase may participate in the proton translocating mechanism. J Biol Chem 2008, 283:13044-13052.
77. Li Q, Mahendra S, Lyon DY, Brunet L, Liga MV, Li D, Alvarez PJ. Antimicrobial nanomaterials for water disinfection and microbial control: potential applications and implications. Water Res 2008, 42:4591-4602.
78. Chen X, Schluesener HJ. Nanosilver: a nanoproduct in medical application. Toxicol Lett 2008, 176:1-12.
79. Wigginton NS, Titta AD, Piccapietra F, Dobias J, Nesatyy V, Suter MJ, Bernier-Latmani R. Binding of silver nanoparticles to bacterial proteins depends on surface modifications and inhibits enzymatic activity. Environ Sci Technol 2010, 44:2163-2168.
80. Lok C, Ho C, Chen R, He Q, Yu W, Sun H, Tam PK, Chiu JF, Che CM. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J Proteome Res 2006, 5:916-924.
81. Iijima S, Ichihashi T. Structureal instability of ultrafine particles of metals. Phys Rev Lett 1986, 56:616-619.
82. Ino S. Epitaxial growth of metals on rocksalt faces cleaved in vacuum. II. Orientation and structure of gold particles formed in ultrahigh vacuum. J Phys Soc Jpn 1966, 21:346-362.
83. Ino S, Ogawa S. Multiply twinned particles at earlier stages of gold film formation on alkalihalide crystals. J Phys Soc Jpn 1967, 22:1365-1374.
84. Ino S. Stability of multiply-twinned particles. J Phys Soc Jpn 1969, 27:941-953.
85. Ajayan PM, Marks LD. Quasimelting and phases of small particles. Phys Rev Lett 1988, 60:585-587.
86. Vitos L, Ruban AV, Skriver HL, Kollar J. The surface energy of metals. Surf Sci 1998, 411:186-202.
87. Giorgio S, Urban J. Fivefold and threefold symmetries in silver clusters. Appl Phys Lett 1988, 52:1467-1468.
88. Hatchett DW, White HS. Electrochemistry of sulfur adlayers on the low-index faces of silver. J Phys Chem 1996, 100:9854-9859.
89. Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramírez JP, Yacaman MJ. The bactericidal effect of silver nanoparticles. Nanotechnology 2005, 16:2346-2353.
90. Elechiguerra JL, Burt JL, Morones JR, Bragado AC, Gao X, Lara HH, Yacaman MJ. Interaction of silver nanoparticles with HIV-1. J Nanobiotechnol 2005, 3:6.
91. Pal S, Tak YK, Song JM. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl Environ Microbiol 2007, 27:1712-1720.
92. Carlson C, Hussain SM, Schrand AM, Braydich-Stolle LK, Hess KL, Jones RL, Schlager JJ. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B 2008, 112:13608-13619.
93. Gogoi SK, Gopinath P, Paul A, Ramesh A, Ghosh SS, Chattopadhyay A. Green fluorescent protein-expressing Escherichia coli as a model system for investigating the antimicrobial activities of silver nanoparticles. Langmuir 2006, 22:9322-9328.
94. Arora S, Jain J, Rajwade JM, Paknikar KM. Cellular responses induced by silver nanoparticles: in vitro studies. Toxicol Lett 2008, 179:93-100.
95. Santoro CM, Duchsherer NL, Grainger DW. Antimicrobial efficacy and ocular cell toxicity from silver nanoparticles. Nanobiotechnology 2007, 3:55-65.
96. Liu R, Sun F, Zhang L, Zong W, Zhao X, Wang L, Wu R, Hao X. Evaluation on the toxicity of nanoAg to bovine serum albumin. Sci Total Environ 2009, 407:4184-4188.
97. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 2005, 19:975-983.
98. Navarro E, Piccapietra F, Wagner B, Marconi F, Kaegi R, Odzak N, Sigg L, Behra R. Toxicity of Silver Nanoparticles to Chlamydomonas reinhardtii. Environ Sci Technol 2008, 42:8959-8964.
99. Kawata K, Osawa M, Okabe S. In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Environ Sci Technol 2009, 43:6046-6051.
100. Kim S, Choi JE, Choi J, Chung K, Park K, Yi J, Ryu DY. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol In Vitro 2009, 23:1076-1084.
101. Su H, Chou C, Hung D, Lin S, Pao I, Lin JH, Huang FL, Dong RX, Lin JJ. The disruption of bacterial membrane integrity through ROS generation induced by nanohybrids of silver and clay. Biomaterials 2009, 30:5979-5987.
102. Bar-Ilan O, Albrecht RM, Fako VE, Furgeson DY. Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos. Small 2009, 5:1897-1910.
103. Kramer J, Bell R, Smith S, Gorsuch J. Silver nanoparticle tocicity and biocides: need for chemical speciation. Integrated Environ Assess Manage 2009, 5:720-722.
104. Ahamed M, Karns M, Goodson M, Rowe J, Hussain SM, Schlager JJ, Hong Y. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol Appl Pharmacol 2008, 233:404-410.
105. Selva J, Martinez SE, Buceta D, Rodriguez-Vazquez MJ, Blanco MC, Lopez-Quintela MA, Egea G. Silver sub-nanoclusters electrocatalyze ethanol oxidation and provide protection against ethanol toxicity in cultured mammalian cells. J Am Chem Soc 2010, 132:6947-6954.
106. Sur I, Cam D, Kahraman M, Baysal A, Culha1 M. Interaction of multi-functional silver nanoparticles with living cells. Nanotechnology 2010, 21:175104.
107. Barrena R, Casals E, Colón J, Font X, Sánchez A, Sáncheza A, Puntes V. Evaluation of the ecotoxicity of model nanoparticles. Chemosphere 2009, 75:850-857.
108. Decher G. Fuzzy nanoassemblies: toward layered polymeric multicomposites. Science 1997, 277:1232-1237.
109. Lee D, Cohen RE, Rubner MF. Antibacterial properties of Ag nanoparticle loaded multilayers and formation of magnetically directed antibacterial microparticles. Langmuir 2005, 21:9651-9659.
110. Hyde K, Rusa M, Hinestroza J. Layer-by-layer deposition of polyelectrolyte nanolayers on natural fibres: cotton. Nanotechnology 2005, 16:S422-S428.
111. Dubas ST, Kumlangdudsan P, Potiyaraj P. Layer-by-layer deposition of antimicrobial silver nanoparticles on textile fibers. Colloid Surf A 2006, 289:105-109.
112. Li Z, Lee D, Sheng X, Cohen RE, Rubner MF. Two-level antibacterial coating with both release-killing and contact-killing capabilities. Langmuir 2006, 22:9820-9823.
113. Yuan W, Ji J, Fu J, Shen J. A facile method to construct hybrid multilayered films as a strong and multifunctional antibacterial coating. J Biomed Mater Res 2008, 85B:556-563.
114. Roe D, Karandikar B, Bonn-Savage N, Gibbins B, Roullet JB. Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. J Antimicrob Chemother 2008, 61:869-876.
115. Wang Q, Yu H, Zhong L, Liu J, Sun J, Shen J. Incorporation of silver ions into ultrathin titanium phosphate films: in situ reduction to prepare silver nanoparticles and their antibacterial activity. Chem Mater 2006, 18:1988-1994.
116. Zan X, Su Z. Incorporation of nanoparticles into polyelectrolyte multilayers via counterion exchange and in situ reduction. Langmuir 2009, 25:12355-12360.
117. Bois L, Chassagneux F, Battie Y, Bessueille F, Mollet L, Parola S, Destouches N, Toulhoat N, Moncoffre N. Chemical growth and photochromism of silver nanoparticles into a mesoporous titania template. Langmuir 2010, 26:1199-1206.
118. Vasilev K, Sah V, Anselme K, Ndi C, Mateescu M, Dollmann B, Martinek P, Ys H, Ploux L, Griesser HJ. Tunable antibacterial coatings that support mammalian cell growth. Nano Lett 2010, 10:202-207.
119. Inoue Y, Uota M, Torikai T, Watari T, Noda I, Hotokebuchi T, Yada M. Antibacterial properties of nanostructured silver titanate thin films formed on a titanium plate. J Biomed Mater Res 2010, 92A:1171-1180.
120. Tankhiwale R, Bajpai SK. Silver-nanoparticle-loaded chitosan lactate films with fair antibacterial properties. J Appl Polym Sci 2010, 115:1894-1900.
121. Nickel U, Castell AZ, Poppl K, Schneider S. A silver colloid produced by reduction with hydrazine as support for highly sensitive surface-enhanced Raman spectroscopy. Langmuir 2000, 16:9087-9091.
122. Kumar A, Vemula PK, Ajayan PM, John G. Silver-nanoparticle-embedded antimicrobial paints based on vegetable oil. Nat Mater 2008, 7:236-241.
123. Galya T, Sedlarik V, Kuritka I, Novotny R, Sedlarikova J, Saha P. Antibacterial poly(vinyl alcohol) film containing silver nanoparticles: preparation and characterization. J Appl Polym Sci 2008, 110:3178-3185.
124. Sheel DW, Brook LA, Yates HM. Controlled nanostructured silver coated surfaces by atmospheric pressure chemical vapour deposition. Chem Vapor Deposition 2008, 14:14-24.
125. Saulou C, Despax B, Raynaud P, Zanna S, Marcus P, Bonin MM. Plasma deposition of organosilicon polymer thin films with embedded nanosilver for prevention of microbial adhesion. Appl Surf Sci 2009, 256S:S35-S39.
126. Mattox DM. Handbook of Physical Vapor Deposition (PVD) Processing: Film Formation, Adhesion, Surface Preparation and Contamination Control. Westwood, NJ: Noyes Publications; 1998
127. Chu PK, Chen JY, Wang LP, Huang N. Plasma-surface modification of biomaterials. Mater Sci Eng R 2002, 36:143-206.
128. Liu X, Chu PK, Ding C. Surface modification of titanium, titanium alloys, and related materials for biomedical applications. Mater Sci Eng R 2004, 47:49-121.
129. Pelletier J, Anders A. Plasma-based ion implantation and deposition: a review of physics, technology, and applications. IEEE Trans Plasma Sci 2005, 33:1-72.
130. Chu PK. Enhancement of surface properties of biomaterials using plasma-based technologies. Surf Coatings Technol 2007, 201:8076-8082.
131. Huang N, Yang P, Leng YX, Wang J, Sun H, Chen JY, Wan GJ. Surface modification of biomaterials by plasma immersion ion implantation. Surf Coatings Technol 2004, 186:218-226.
132. Wan YZ, Raman S, He F, Huang Y. Surface modification of medical metals by ion implantation of silver and copper. Vacuum 2007, 81:1114-1118.
133. Zhao J, Feng HJ, Tang HQ, Zheng JH. Bactericidal and corrosive properties of silver implanted TiN thin films coated on AISI317 stainless steel. Surf Coatings Technol 2007, 201:5676-5679.
134. Wang J, Li J, Shen L, Ren L, Xu Z, Zhao A, Leng Y, Huang N. The biomedical properties of polyethylene terephthalate surface modified by silver ion implantation. Nucl Instrum Methods B 2007, 257:141-145.
135. Zhang W, Luo Y, Wang H, Pu S, Chu PK. Biocompatibility of silver and copper plasma doped polyethylene. Surf Coatings Technol 2009, 203:2550-2553.
136. Zhang W, Luo Y, Wang H, Jiang J, Pu S, Chu PK. Ag and Ag/N2 plasma modification of polyethylene for the enhancement of antibacterial properties and cell growth/proliferation. Acta Biomater 2008, 4:2028-2036.
137. Wang G, Liu X, Gao J, Ding C. In vitro bioactivity and phase stability of plasma-sprayed nanostructured 3Y-TZP coatings. Acta Biomater 2009, 5:2270-2278.
138. Liu X, Zhao X, Fu RKY, Ho JPY, Ding C, Chu PK. Plasma-treated nanostructured TiO2 surface supporting biomimetic growth of apatite. Biomaterials 2005, 26:6143-6150.
139. Liu X, Zhao X, Li B, Cao C, Dong YQ, Dong Y, Ding C, Chu PK. Bioactive nano-TiO2 surface generated by ultra-violet irradiation. Acta Biomater 2008, 4:544-552.
140. Kertzman Z, Marchal J, Suarez M, Staia MH, Filip P, Kohli P, Aouadi SM. Mechanical, tribological, and biocompatibility properties of ZrN-Ag nanocomposite films. J Biomed Mater Res 2008, 84A:1061-1067.
141. Datta D, Bhattacharyya SR, Shyjumon I, Ghose D, Hippler R. Production and deposition of energetic metal nanocluster ions of silver on Si substrates. Surf Coatings Technol 2009, 203:2452-2457.
142. Kim SE, Han YH, Lee B, Lee JC. One-pot fabrication of various silver nanostructures on substrates using electron beam irradiation. Nanotechnology 2010, 21:075302.
143. Burns JW. Biology takes centre stage. Nat Mater 2009, 8:441-443.